Bart Vanderborght

3.2k total citations
47 papers, 1.7k citations indexed

About

Bart Vanderborght is a scholar working on Hepatology, Epidemiology and Molecular Biology. According to data from OpenAlex, Bart Vanderborght has authored 47 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hepatology, 21 papers in Epidemiology and 10 papers in Molecular Biology. Recurrent topics in Bart Vanderborght's work include Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (16 papers) and Liver Disease Diagnosis and Treatment (12 papers). Bart Vanderborght is often cited by papers focused on Hepatitis C virus research (18 papers), Hepatitis B Virus Studies (16 papers) and Liver Disease Diagnosis and Treatment (12 papers). Bart Vanderborght collaborates with scholars based in Brazil, Belgium and Canada. Bart Vanderborght's co-authors include Marleen Vanden Haesevelde, Eric Saman, Wim Quint, Guido van der Groen, Remko Leys, Clara Fumiko Tachibana Yoshida, Lindsey Devisscher, Wink de Boer, J. Atherton and Martin J. Blaser and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Bart Vanderborght

46 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bart Vanderborght Brazil 20 757 504 448 446 370 47 1.7k
Rainer Duchmann Germany 22 648 0.9× 429 0.9× 215 0.5× 324 0.7× 138 0.4× 61 3.2k
Fernando Dı́az Spain 20 837 1.1× 371 0.7× 748 1.7× 281 0.6× 53 0.1× 38 1.7k
Bittoo Kanwar United States 17 533 0.7× 65 0.1× 333 0.7× 398 0.9× 630 1.7× 31 1.8k
Ulrike Bode Germany 21 514 0.7× 269 0.5× 385 0.9× 190 0.4× 36 0.1× 46 2.3k
C Marche France 19 668 0.9× 182 0.4× 78 0.2× 412 0.9× 448 1.2× 82 1.5k
G. L. Toms United Kingdom 24 1.4k 1.9× 163 0.3× 643 1.4× 522 1.2× 59 0.2× 79 1.9k
Mohammad Naderi Iran 20 1.7k 2.2× 189 0.4× 1.3k 2.9× 487 1.1× 20 0.1× 78 2.5k
Vincent Aubert Switzerland 20 248 0.3× 165 0.3× 153 0.3× 407 0.9× 289 0.8× 74 1.1k
S. Keay United States 23 994 1.3× 303 0.6× 34 0.1× 148 0.3× 112 0.3× 39 1.6k
Harold W. Lischner United States 24 468 0.6× 127 0.3× 45 0.1× 397 0.9× 500 1.4× 42 1.6k

Countries citing papers authored by Bart Vanderborght

Since Specialization
Citations

This map shows the geographic impact of Bart Vanderborght's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bart Vanderborght with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bart Vanderborght more than expected).

Fields of papers citing papers by Bart Vanderborght

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bart Vanderborght. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bart Vanderborght. The network helps show where Bart Vanderborght may publish in the future.

Co-authorship network of co-authors of Bart Vanderborght

This figure shows the co-authorship network connecting the top 25 collaborators of Bart Vanderborght. A scholar is included among the top collaborators of Bart Vanderborght based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bart Vanderborght. Bart Vanderborght is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bigio, Benedetta, Ricardo A. S. Lima‐Filho, Felipe Kenji Sudo, et al.. (2025). Sex differences in mitochondrial free-carnitine levels in subjects at-risk and with Alzheimer’s disease in two independent study cohorts. Molecular Psychiatry. 30(6). 2573–2583. 2 indexed citations
2.
Santos, Luís E., Paulo Mattos, Cláudia Drummond, et al.. (2025). Performance of plasma biomarkers for diagnosis and prediction of dementia in a Brazilian cohort. Nature Communications. 16(1). 2911–2911. 4 indexed citations
3.
Vanderborght, Bart, Kevin De Muynck, Eva Gijbels, et al.. (2023). Transient Kupffer cell depletion and subsequent replacement by infiltrating monocyte‐derived cells does not alter the induction or progression of hepatocellular carcinoma. International Journal of Cancer. 152(12). 2615–2628. 6 indexed citations
4.
Muynck, Kevin De, Bart Vanderborght, Federico F. De Ponti, et al.. (2023). Kupffer Cells Contested as Early Drivers in the Pathogenesis of Primary Sclerosing Cholangitis. American Journal Of Pathology. 193(4). 366–379. 9 indexed citations
5.
Karmirian, Karina, Mariana Holubiec, Livia Goto‐Silva, et al.. (2022). Modeling Alzheimer’s Disease Using Human Brain Organoids. Methods in molecular biology. 2561. 135–158. 15 indexed citations
6.
Gijbels, Eva, Kevin De Muynck, Bart Vanderborght, et al.. (2022). Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease. Genes & Diseases. 10(1). 18–21. 1 indexed citations
7.
Degroote, Helena, Bart Vanderborght, Xavier Verhelst, et al.. (2021). NOX1 inhibition attenuates the development of a pro‐tumorigenic environment in experimental hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 40(1). 40–40. 24 indexed citations
8.
Lourenco, Mychael V., Felipe C. Ribeiro, Felipe Kenji Sudo, et al.. (2020). Cerebrospinal fluid irisin correlates with amyloid‐β, BDNF, and cognition in Alzheimer's disease. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 12(1). e12034–e12034. 52 indexed citations
9.
Vanderborght, Bart, Sander Lefere, Hans Van Vlierberghe, & Lindsey Devisscher. (2020). The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma. Cells. 9(11). 2382–2382. 22 indexed citations
10.
Morice, Yoann, Jean‐François Cantaloube, Stéphanie Beaucourt, et al.. (2006). Molecular epidemiology of hepatitis C virus subtype 3a in injecting drug users. Journal of Medical Virology. 78(10). 1296–1303. 52 indexed citations
11.
França, Paulo Henrique Condeixa de, Jorge González, María Silvina Munné, et al.. (2004). Strong Association between Genotype F and Hepatitis B Virus (HBV) e Antigen-Negative Variants among HBV-Infected Argentinean Blood Donors. Journal of Clinical Microbiology. 42(11). 5015–5021. 30 indexed citations
12.
Figueiredo, Céu, Françis Mégraud, Salvador Peña, et al.. (1999). Geographic distribution of vacA allelic types of Helicobacter pylori. Gastroenterology. 116(4). 823–830. 369 indexed citations
13.
Teles, Sheila Araújo, Regina Maria Bringel Martins, Bart Vanderborght, et al.. (1999). Hepatitis B Virus: Genotypes and Subtypes in Brazilian Hemodialysis Patients. Artificial Organs. 23(12). 1074–1078. 42 indexed citations
14.
Brindeiro, Rodrigo, et al.. (1999). Sequence Diversity of the Reverse Transcriptase of Human Immunodeficiency Virus Type 1 from Untreated Brazilian Individuals. Antimicrobial Agents and Chemotherapy. 43(7). 1674–1680. 53 indexed citations
15.
Moraes, M. E., et al.. (1998). Characterization of a new HLA‐B39 allele, B*3913, in a Brazilian Caucasian. Tissue Antigens. 52(6). 583–586. 4 indexed citations
16.
Martin, Regina Matsunaga, et al.. (1997). Soroprevalência do vírus da hepatite C na população em diálise de Goiânia, GO. Revista da Sociedade Brasileira de Medicina Tropical. 30(2). 113–117. 10 indexed citations
17.
Rosa, Heitor, et al.. (1996). Short Report: Association between Leprosy and Hepatitis C Infection: A Survey in a Region of Central Brazil. American Journal of Tropical Medicine and Hygiene. 55(1). 22–23. 10 indexed citations
18.
Martins, Regina Maria Bringel, Bart Vanderborght, Jorge Brito, et al.. (1996). Prevalence of hepatitis C antibodies among health care workers at high risk for blood exposure. Revista do Instituto de Medicina Tropical de São Paulo. 38(4). 309–310. 2 indexed citations
19.
Vanderborght, Bart, et al.. (1993). Prevalence of Anti‐Hepatitis C Virus in the Blood Donor Population of Rio de Janeiro. Vox Sanguinis. 65(2). 122–125. 18 indexed citations
20.
Yoshida, Clara Fumiko Tachibana, et al.. (1992). Human antibodies to dengue and yellow fever do not react in diagnostic assays for hepatitis C virus.. PubMed. 25(11). 1131–5. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Rainer Duchmann Breakdown of academic impact, for papers by Fernando Dı́az Breakdown of academic impact, for papers by Bittoo Kanwar Breakdown of academic impact, for papers by Ulrike Bode Breakdown of academic impact, for papers by C Marche Breakdown of academic impact, for papers by G. L. Toms Breakdown of academic impact, for papers by Mohammad Naderi Breakdown of academic impact, for papers by Vincent Aubert Breakdown of academic impact, for papers by S. Keay Breakdown of academic impact, for papers by Harold W. Lischner
Rankless by CCL
2026